ArticleKidney medicine2026
Diastolic Blood Pressure Variability Predicts Cardiovascular Outcomes in CKD, Especially in Advanced Stages.
Article in Kidney medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rationale & Objective: Chronic kidney disease (CKD) is associated with a high risk of cardiovascular events. However, the role of diastolic blood pressure variability (DBPV) in predicting these outcomes, particularly in comparison to systolic blood pressure variability (SBPV), remains unclear. This study aimed to assess the prognostic value of DBPV in patients with CKD. Study Design: A retrospective cohort study was conducted. Setting & Participants: A total of 1,245 adults diagnosed with CKD (stages G3a, G3b, and G4-5) from the Seventh Affiliated Hospital of Sun Yat-sen University from 2019 to 2023 were included in the study. Exposures: DBPV parameters, including 24-hour DBP standard deviation (SD), coefficient of variation, and nocturnal decline rate, were measured using 24-hour ambulatory blood pressure monitoring. Outcomes: The primary outcome was all-cause mortality. Secondary outcomes included cardiovascular death and heart failure hospitalization. Analytical Approach: Cox proportional hazards models were used to analyze the associations, adjusting for multiple confounding factors, such as SBP, SBPV, and traditional cardiovascular risk factors. Interaction analyses were performed by CKD stage. The incremental predictive value of DBPV was evaluated using integrated discrimination improvement and net reclassification improvement. Results: During a median follow-up of 3.2 years, higher 24-hour DBP SD was independently associated with an increased risk of all-cause mortality (hazard ratio [HR], 1.08; 95% CI, 1.03-1.13; Limitations: The study had a single-center design, lacked non-CKD and stage 1-2 CKD controls, and did not have longitudinal DBPV data. Conclusions: DBPV independently predicts adverse cardiovascular outcomes in patients with CKD, with stronger associations in advanced stages. It adds incremental value to SBPV in predicting cardiovascular events in this high-risk population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.